Advertisement
Advertisement
LQDA
Liquidia Corporation Common Stock
70.27
USDSponsored
+1.65
+2.40%
Aug 24, 15:59 UTC -4
Closed
After-Market
69.71
-0.56
-0.80%
LQDA Earnings Reports
Positive Surprise Ratio
LQDA beat 11 of 32 last estimates.
34%
Next Report
Date of Next Report
Nov 02, 2026
Estimate for Q3 26 (Revenue/ EPS)
$198.53M
/$0.92
Implied change from Q2 26 (Revenue/ EPS)
+15.64%
/+24.32%
Implied change from Q3 25 (Revenue/ EPS)
+265.33%
/-2400.00%
Liquidia Corporation Common Stock earnings per share and revenue
On Aug 12, 2026, LQDA reported earnings of 0.74 USD per share (EPS) for Q2 26, missing the estimate of 0.75 USD, resulting in a -2.34% surprise. Revenue reached 171.68 million, compared to an expected 171.91 million, with a -0.13% difference. The market reacted with a -10.52% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 6 analysts forecast an EPS of 0.92 USD, with revenue projected to reach 198.53 million USD, implying an increase of 24.32% EPS, and increase of 15.64% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Eton Pharmaceutcials, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
$0.11
Actual
$0.35
Surprise
+198.38%
Alvotech Ordinary Shares
Report Date
Aug 19, 2026 For Q2 26
Estimate
-$0.02
Actual
-$0.11
Surprise
-300.00%
Abeona Therapeutics Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.23
Actual
-$0.35
Surprise
-49.19%
Prenetics Global Limited Class A Ordinary Share
Report Date
Aug 18, 2026 For Q2 26
Estimate
-$0.71
Actual
-$0.53
Surprise
+26.30%
Alpha Cognition Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.39
Actual
-$0.40
Surprise
-0.05%
ProMIS Neurosciences Inc. Common Shares (ON)
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$1.39
Actual
-$1.28
Surprise
+8.07%
TuHURA Biosciences, Inc. Common Stock
Report Date
Aug 14, 2026 For Q2 26
Estimate
-$0.14
Actual
-$0.14
Surprise
+5.34%
Outlook Therapeutics, Inc. Common Stock
Report Date
Aug 14, 2026 For Q3 26
Estimate
-$0.09
Actual
-$0.09
Surprise
+5.46%
Lantern Pharma Inc. Common Stock
Report Date
Aug 14, 2026 For Q2 26
Estimate
-$0.38
Actual
-$0.28
Surprise
+27.76%
PDS Biotechnology Corporation Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.13
Actual
-$0.18
Surprise
-35.75%
FAQ
What were Liquidia Corporation Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Liquidia Corporation Common Stock reported EPS of $0.74, missing estimates by -2.34%, and revenue of $171.68M, -0.13% below expectations.
How did the market react to Liquidia Corporation Common Stock's Q2 2026 earnings?
The stock price moved down -10.52%, changed from $88.05 before the earnings release to $78.79 the day after.
When is Liquidia Corporation Common Stock expected to report next?
The next earning report is scheduled for Nov 02, 2026.
What are the forecasts for Liquidia Corporation Common Stock's next earnings report?
Based on 6
analysts, Liquidia Corporation Common Stock is expected to report EPS of $0.92 and revenue of $198.53M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement